Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:26:37.252Z.
Calculation as of: 2026-10-06T15:26:37.252Z.
Quote observation: 2026-10-06T15:25:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3e31615b66e5acc6c2b7b3f8a521ec69124b31f47383f0f9627e8176a83f275d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Definium Therapeutics, Inc.
Market Cap
$4.72B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Operating Cash Flow Yield
4.66%
TTM Avg
5.45%
3Y Avg
3.91%
5Y Avg
2.86%
Market Cap
$4.65B
Operating Cash Flow Yield
7.46%
TTM Avg
6.65%
3Y Avg
6.29%
5Y Avg
5.66%
Market Cap
$4.59B
Operating Cash Flow Yield
0.99%
TTM Avg
0.60%
3Y Avg
0.60%
5Y Avg
0.60%
Market Cap
$4.86B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.89B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.91B
Operating Cash Flow Yield
N/A
TTM Avg
0.78%
3Y Avg
0.73%
5Y Avg
0.73%
Market Cap
$4.44B
Operating Cash Flow Yield
N/A
TTM Avg
6.45%
3Y Avg
5.17%
5Y Avg
5.55%
Market Cap
$4.41B
Operating Cash Flow Yield
N/A
TTM Avg
5.97%
3Y Avg
5.97%
5Y Avg
5.97%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.72B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 4.66% | 5.45% | 3.91% | 2.86% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 7.46% | 6.65% | 6.29% | 5.66% |
| BillionToOne, Inc. (BLLN)vs › | $4.59B | 0.99% | 0.60% | 0.60% | 0.60% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.89B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.91B | N/A | 0.78% | 0.73% | 0.73% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | N/A | 6.45% | 5.17% | 5.55% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | N/A | 5.97% | 5.97% | 5.97% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
